The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research


Original post, click here
Primary Outcome Measures:
Secondary Outcome Measures:

  • clinical efficacy: control required GH level [ Time Frame: 30 years ]

    To compare control required GH level of different treatment models (surgery, drug and radiotherapeutics treatment) in patients with acromegaly in China

  • Cost-effectiveness [ Time Frame: 30 years ]

    To compare cost for acromegaly of different treatment models (surgery, drug and radiotherapeutics treatment) in patients with acromegaly in China

The study was designed to answer some of the most important questions about the treatment modalities of acromegaly, the relevance of these treatment modalities to patients’ clinical outcomes and the economic impact of treatment programs on patients. These answers may be of great help to the treatment of these populations and may also help to make treatment and related health decisions in the future.

This study only collects the patient’s medical information during the study and does not interfere with the patient’s treatment. Each patient will be assigned a unique patient identification number for the study. The sites will maintain a confidential decode list that enables the study staff at the site to link the assigned patient identification number with the patient’s medical records for extraction of study-required data. These registries will be maintained following International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) and the respective local privacy laws and requirements.